Don't lose your bladder to NMIBC. See how the "Cancer Bioshield" of Anktiva and BCG uses T-cells to provide durable, ...

Chemotherapy used to target and kill bladder cancer cells may trigger an inflammatory response that ultimately may make the cancer more resistant to treatment, according to new research from ...

Researchers investigating the role of progranulin in cancer progression have previously identified the signaling receptor ...

It remains unclear whether the planned trial will use Anktiva, and its timing and design are undisclosed. ・NantWorks led ...

Researchers discover novel targets for bladder cancer therapeutics and demonstrate that a new combination of existing drugs, including statins, blocks tumor growth in mice. Like all cancers, bladder ...

Announcing a new article publication for BIO Integration journal. Bladder cancer (BLCA) is one of the most common malignancies and the second most frequent urogenital tract tumor. Cell and gene ...

By using mRNA molecules to “remodel” parts of the immune system, researchers generated T cells that can slow the growth of ...

Non-muscle invasive bladder cancer is cancer that’s only in the inner lining of your bladder. It hasn’t grown into the muscle wall. Your doctor may also call it superficial bladder cancer, urothelial ...

Bladder cancer patient Patrick Delahoussaye is benefiting from a new chemotherapy treatment, called a “pretzel.” ...